Skip to main content
Log in

All-trans Retinoic Acid-incorporated Glycol Chitosan Nanoparticles Regulate Macrophage Polarization in Pg-LPS-Induced Inflammation

  • Published:
Current Medical Science Aims and scope Submit manuscript

Abstract

Objective

The occurrence and development of inflammation are closely correlated to the polarization of macrophages. All-trans retinoic acid (ATRA) has been proven to promote the polarization of macrophages from M1 to M2, but this lacks an effective carrier to participate in the biological response. The present study aims to determine whether retinoic acid-incorporated glycol chitosan (RA-GC) nanoparticles can regulate macrophage polarization in Porphyromonas gingivalis-lipopolysaccharide (Pg-LPS)-induced inflammation.

Methods

Mouse 264.7 cell lines were treated with 1 µg/mL Pg-LPS to induce inflammation. After the effects of ATRA and RA-GC on the activity of macrophages were detected by CCK-8 assay, cells induced with Pg-LPS were assigned to the blank control group (GC) nanoparticles without ATRA, and experimental groups (GC nanoparticles loaded with different concentrations of ATRA: 1, 10 and 100 µg/mL). The effects of RA-GC on inflammatory cytokines tumor necrosis factor-α, interleukin (IL)-10 and IL-12 in macrophages were detected by enzyme-linked immunosorbent assay (ELISA). Subsequently, the effects of GC nanoparticles loaded with/without ATRA on macrophage polarization in an inflammatory environment were detected by RT-PCR and Western blotting.

Results

The results revealed that RA-GC had no significant effect on macrophage activity. However, RA-GC could effectively inhibit the Pg-LPS-induced inflammatory factor expression in macrophages. Meanwhile, the experimental results confirmed that RA-GC could downregulate the expression of inducible nitric oxide synthase (iNOS) (a marker of M1 macrophages) and upregulate the expression of mannose receptor and Arginase-1 (a marker of M2 macrophages) in a dose-dependent manner.

Conclusion

The present study confirms that RA-GC can promote the M2 polarization of macrophages in an inflammatory environment, and proposes this as a promising target for the clinical treatment of Pg-LPS-related diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol, 2005, 5(12): 953–964

    Article  CAS  Google Scholar 

  2. Martinez FO, Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep, 2014, 6: 13

    Article  Google Scholar 

  3. Shrivastava R, Shukla N. Attributes of alternatively activated (M2) macrophages. Life Sci, 2019,(224):222-231

  4. Spiller KL, Koh TJ. Macrophage-based therapeutic strategies in regenerative medicine. Adv Drug Deliv Rev, 2017, 122: 74–83

    Article  CAS  Google Scholar 

  5. Martinez FO, Sica A, Mantovani A, et al. Macrophage activation and polarization. Front Biosci, 2008, 13: 453–461

    Article  CAS  Google Scholar 

  6. Mirza R, Koh TJ. Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine, 2011, 56(2): 256–264

    Article  CAS  Google Scholar 

  7. Kigerl KA, Gensel JC, Ankeny DP, et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci, 2009, 29(43): 13435–13444

    Article  CAS  Google Scholar 

  8. Hu G, Guo M, Xu J, et al. Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation. Front Immunol, 2019, 10: 1998

    Article  CAS  Google Scholar 

  9. Yuan Y, Long L, Liu J, et al. The double-edged sword effect of macrophage targeting delivery system in different macrophage subsets related diseases. J Nanobiotechnol, 2020, 18(1): 168

    Article  CAS  Google Scholar 

  10. Altucci L, Leibowitz MD, Ogilvie KM, et al. RAR and RXR modulation in cancer and metabolic disease. Nat Rev Drug Disc, 2007, 6(10): 793–810

    Article  CAS  Google Scholar 

  11. Dar PA, Singh LR, Kamal MA, et al. Unique Medicinal Properties of Withania somnifera: Phytochemical Constituents and Protein Component. Curr Pharm Design, 2016, 22(5): 535–540

    Article  CAS  Google Scholar 

  12. Yan Q, Li Y, Cheng N, et al. Effect of retinoic acid on the function of lipopolysaccharide-stimulated bone marrow stromal cells grown on titanium surfaces. Inflamm Res, 2015, 64(1): 63–70

    Article  CAS  Google Scholar 

  13. Zhong C, Pu L, Fang M, et al. ATRA Regulates Innate Immunity in Liver Ischemia/Reperfusion Injury via RARalpha/Akt/Foxo1 Signaling. Biol Pharm Bull, 2018, 41(4): 530–535

    Article  CAS  Google Scholar 

  14. Lee B, Wu CY, Lin YW, et al. Synergistic activation of Arg1 gene by retinoic acid and IL-4 involves chromatin remodeling for transcription initiation and elongation coupling. Nucleic Acids Res, 2016, 44(16): 7568–7579

    Article  Google Scholar 

  15. Vellozo NS, Pereira-Marques ST, Cabral-Piccin MP, et al. All-Trans Retinoic Acid Promotes an M1- to M2-Phenotype Shift and Inhibits Macrophage-Mediated Immunity to Leishmania major. Front Immunol, 2017, 8: 1560

    Article  Google Scholar 

  16. Szuts EZ, Harosi FI. Solubility of retinoids in water. Arch Biochem Biophys, 1991, 287(2): 297–304

    Article  CAS  Google Scholar 

  17. Conley BA, Egorin MJ, Sridhara R, et al. Phase I clinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics. Cancer Chemoth Pharmacol, 1997, 39(4): 291–299

    Article  CAS  Google Scholar 

  18. Frankel SR, Eardley A, Lauwers G, et al. The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann Intern Med, 1992, 117(4): 292–296

    Article  CAS  Google Scholar 

  19. Kim IY, Seo SJ, Moon HS, et al. Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv, 2008, 26(1): 1–21

    Article  CAS  Google Scholar 

  20. Vasconcelos DP, Fonseca AC, Costa M, et al. Macrophage polarization following chitosan implantation. Biomaterials, 2013, 34(38): 9952–9959

    Article  CAS  Google Scholar 

  21. Bhattarai N, Ramay HR, Gunn J, et al. PEG-grafted chitosan as an injectable thermosensitive hydrogel for sustained protein release. J Control Release, 2005, 103(3): 609–624

    Article  CAS  Google Scholar 

  22. Park JS, Koh YS, Bang JY, et al. Antitumor effect of all-trans retinoic acid-encapsulated nanoparticles of methoxy poly(ethylene glycol)-conjugated chitosan against CT-26 colon carcinoma in vitro. J Pharm Sci, 2008, 97(9): 4011–4019

    Article  CAS  Google Scholar 

  23. Chung KD, Jeong YI, Chung CW, et al. Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells. Int J Pharm, 2012, 422(1–2): 454–461

    Article  CAS  Google Scholar 

  24. Jeong YI, Kim SH, Jung TY, et al. Polyion complex micelles composed of all-trans retinoic acid and poly (ethylene glycol)-grafted-chitosan. J Pharm Sci, 2006, 95(11): 2348–2360

    Article  CAS  Google Scholar 

  25. Thunemann AF, Beyermann J, Kukula H. Poly(ethylene oxide)-b-poly(l-lysine) Complexes with Retinoic Acid. Macromolecules, 2000, 33(16): 5906–5911

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Bin Shi or Yi Lin.

Ethics declarations

The authors declare that there are no conflicts of interest in this work.

Additional information

The study was supported by the Natural Science Foundation of Fujian Province (No. 2018J01245).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

He, Tr., Tang, Xy., Yan, Q. et al. All-trans Retinoic Acid-incorporated Glycol Chitosan Nanoparticles Regulate Macrophage Polarization in Pg-LPS-Induced Inflammation. CURR MED SCI 42, 974–980 (2022). https://doi.org/10.1007/s11596-022-2602-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-022-2602-8

Key words

Navigation